Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tiracizine HCl, a new class I antiarrhythmic drug, was studied in patients with ischemic heart disease and shown to decrease myocardial contractile function.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | Tiracizine HCl, a new class I antiarrhythmic drug, was studied in patients with ischemic heart disease and shown to decrease myocardial contractile function. |
Synonyms | AWD-19-166, AWD19166, Bonnecor, AWD 19 166, Tiracizine Hydrochloride |
Molecular Weight | 403.9 |
Formula | C21H26ClN3O3 |
CAS No. | 78816-67-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tiracizine HCl 78816-67-8 AWD-19-166 AWD 19166 AWD19166 Bonnecor AWD 19 166 AWD-19166 Tiracizine Hydrochloride inhibitor inhibit